ProfileGDS5678 / 1435097_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 20% 20% 20% 20% 19% 24% 20% 20% 19% 20% 19% 20% 20% 19% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5075420
GSM967853U87-EV human glioblastoma xenograft - Control 22.4742820
GSM967854U87-EV human glioblastoma xenograft - Control 32.4828820
GSM967855U87-EV human glioblastoma xenograft - Control 42.42120
GSM967856U87-EV human glioblastoma xenograft - Control 52.4122619
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6323124
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5196120
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4557120
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4320419
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4569920
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4545319
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4406320
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4721120
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4595819